GoodRx Holdings [GDRX] vs Veeva Systems [VEEV] Detailed Stock Comparison
GoodRx Holdings
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: GoodRx Holdings wins in 7 metrics, Veeva Systems wins in 12 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | GoodRx Holdings | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 51.89 | 60.37 | GoodRx Holdings |
| Price-to-Book Ratio | 2.53 | 7.46 | GoodRx Holdings |
| Debt-to-Equity Ratio | 85.15 | 1.24 | Veeva Systems |
| PEG Ratio | 0.52 | 1.51 | GoodRx Holdings |
| EV/EBITDA | 14.03 | 49.47 | GoodRx Holdings |
| Profit Margin (TTM) | 4.33% | 27.34% | Veeva Systems |
| Operating Margin (TTM) | 13.20% | 30.79% | Veeva Systems |
| EBITDA Margin (TTM) | 13.20% | 30.79% | Veeva Systems |
| Return on Equity | 5.27% | 14.06% | Veeva Systems |
| Return on Assets (TTM) | 5.08% | 6.90% | Veeva Systems |
| Free Cash Flow (TTM) | $113.55M | $1.09B | Veeva Systems |
| 1-Year Return | -45.44% | 41.67% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 2.03 | 16.27 | GoodRx Holdings |
| Enterprise Value | $1.89B | $40.11B | Veeva Systems |
| EV/Revenue Ratio | 2.36 | 14.05 | GoodRx Holdings |
| Gross Profit Margin (TTM) | 93.43% | 77.10% | GoodRx Holdings |
| Revenue per Share (TTM) | $2 | $18 | Veeva Systems |
| Earnings per Share (Diluted) | $0.09 | $4.71 | Veeva Systems |
| Beta (Stock Volatility) | 1.24 | 0.96 | Veeva Systems |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
GoodRx Holdings vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| GoodRx Holdings | 2.75% | 26.84% | -5.47% | 18.47% | -6.65% | -1.54% |
| Veeva Systems | -0.61% | 2.65% | 0.46% | 20.12% | 25.02% | 34.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| GoodRx Holdings | -45.44% | -26.51% | -91.37% | -91.37% | -91.37% | -91.37% |
| Veeva Systems | 41.67% | 36.70% | 3.00% | 967.62% | 535.91% | 535.91% |
Performance & Financial Health Analysis: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.62B | $46.47B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 9,122,990 | 947,869 |
| 90 Day Avg. Volume | 3,755,887 | 1,144,810 |
| Last Close | $4.49 | $282.28 |
| 52 Week Range | $3.31 - $8.80 | $194.00 - $296.72 |
| % from 52W High | -48.98% | -4.87% |
| All-Time High | $64.22 (Sep 28, 2020) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -93.01% | -17.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.17% |
| Quarterly Earnings Growth | 0.92% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.27% |
| Operating Margin (TTM) | 0.13% | 0.31% |
| Return on Equity (TTM) | 0.05% | 0.14% |
| Debt to Equity (MRQ) | 85.15 | 1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.84 | $38.11 |
| Cash per Share (MRQ) | $0.81 | $37.14 |
| Operating Cash Flow (TTM) | $190.60M | $1.20B |
| Levered Free Cash Flow (TTM) | $124.38M | $1.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 51.89 | 60.37 |
| Forward P/E | 11.39 | 42.06 |
| PEG Ratio | 0.52 | 1.51 |
| Price to Sales (TTM) | 2.03 | 16.27 |
| Price to Book (MRQ) | 2.53 | 7.46 |
| Market Capitalization | ||
| Market Capitalization | $1.62B | $46.47B |
| Enterprise Value | $1.89B | $40.11B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.36 | 14.05 |
| Enterprise to EBITDA | 14.03 | 49.47 |
| Risk & Other Metrics | ||
| Beta | 1.24 | 0.96 |
| Book Value per Share (MRQ) | $1.84 | $38.11 |
Financial Statements Comparison: GoodRx Holdings vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Revenue/Sales | $202.97M | $759.04M |
| Cost of Goods Sold | $13.36M | $173.82M |
| Gross Profit | $189.61M | $585.22M |
| Research & Development | $31.14M | $184.03M |
| Operating Income (EBIT) | $23.38M | $233.73M |
| EBITDA | $48.22M | $243.55M |
| Pre-Tax Income | $16.67M | $298.82M |
| Income Tax | $5.62M | $70.63M |
| Net Income (Profit) | $11.05M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Cash & Equivalents | $300.98M | $1.96B |
| Total Current Assets | $540.21M | $6.71B |
| Total Current Liabilities | $103.38M | $1.46B |
| Long-Term Debt | $530.63M | $66.57M |
| Total Shareholders Equity | $654.35M | $6.21B |
| Retained Earnings | $-1.43B | $3.68B |
| Property, Plant & Equipment | $34.41M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GDRX | VEEV |
|---|---|---|
| Operating Cash Flow | $37.57M | $810.54M |
| Capital Expenditures | $-142,000 | N/A |
| Free Cash Flow | $-12.46M | $877.16M |
| Debt Repayment | $-1.25M | N/A |
| Common Stock Repurchase | $-99.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GDRX | VEEV |
|---|---|---|
| Shares Short | 6.37M | 4.62M |
| Short Ratio | 5.30 | 3.58 |
| Short % of Float | 0.07% | 0.03% |
| Average Daily Volume (10 Day) | 9,122,990 | 947,869 |
| Average Daily Volume (90 Day) | 3,755,887 | 1,144,810 |
| Shares Outstanding | 382.82M | 162.58M |
| Float Shares | 86.44M | 149.92M |
| % Held by Insiders | 0.13% | 0.09% |
| % Held by Institutions | 1.24% | 0.90% |
Dividend Analysis & Yield Comparison: GoodRx Holdings vs Veeva Systems
| Metric | GDRX | VEEV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |